Both in Pharmaceuticals
Mentari Therapeutics vs Harrow
| Metric | MTRI | HROW |
|---|---|---|
| Price | $18.35 | $28.30 |
| Market cap | $1.07B | $1.06B |
| Today | +17.56% | −3.64% |
| 1 month | — | +3.9% |
| 6 months | — | −8.3% |
| Year to date | — | −42.2% |
| 1 year | — | −26.9% |
| Revenue growth (YoY) | — | +38.6% |
| Gross margin | — | 75.4% |
| Net margin | — | 9.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.5× |
| Net cash | — | -$217.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 48.9% |
| Short % of float | 0.2% | 23.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).